PeptidePedia The community reference

Beyond-use date (revision 12)

Old revision·17:52, 19 Nov 2024·SyringeSybille

This is an old revision of this page, as it stood at 17:52, 19 Nov 2024, saved by SyringeSybille with the summary clarify whether figure is gross or net mass. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Beyond-use date
AbbreviationBUD
Assigned byThe compounder or the person opening the container
BasisCompendial default tables, or product-specific testing
ContrastExpiration date, assigned by the manufacturer from stability data
Topic infobox · conventions

A beyond-use date (BUD) is the date, or date and time, after which a compounded preparation or an opened container is not to be used. It is assigned by the person who prepares or opens the preparation, using compendial default tables or, where available, testing specific to the preparation. It is distinct from an expiration date, which is assigned by a manufacturer on the basis of a formal stability programme conducted on the finished product in its final container.[1][2]

The distinction is one of evidence rather than of vocabulary. An expiration date rests on long-term, intermediate and accelerated stability studies conducted under the conditions specified in ICH Q1A(R2), analysed statistically, and submitted to a regulator; it is a claim about the specific product in the specific container. A beyond-use date generally rests on a table of conservative defaults chosen to be safe across a wide range of preparations, and it is a claim about a class of preparations rather than about the one in hand. The two are therefore not comparable quantities, and a short beyond-use date does not imply a preparation degrades quickly.[3][1]

Beyond-use dates in sterile compounding are limited principally by microbiological risk rather than by chemical degradation. The default periods in USP <797> are graduated by how the preparation was made, by whether sterility testing was performed and passed, and by storage temperature — not by the chemistry of the active substance. Chemical stability is a separate constraint, and where it is shorter it governs.[1]

Definition and contrast with the expiration date

[edit]

An expiration date is the output of a defined regulatory process. Under ICH Q1A(R2), a manufacturer conducts long-term studies at the intended storage condition, intermediate studies where required, and accelerated studies at elevated temperature and humidity, on at least three primary batches in the container closure system intended for marketing. The results are evaluated — under ICH Q1E — to establish a retest period or shelf life, and the date is stated on the label. It applies to the unopened product stored as labelled.[3]

A beyond-use date has none of that apparatus behind it. It applies to a preparation that the manufacturer's stability programme never examined: a container that has been opened, a solution that has been diluted, a lyophilised solid that has been reconstituted, or a preparation compounded from components. The chemistry may be identical; the container's history is not.

Two kinds of date
!PropertyExpiration dateBeyond-use date
Assigned byManufacturerCompounder or dispenser
Evidence baseProduct-specific stability programmeCompendial default table, or preparation-specific testing
Applies toUnopened product, stored as labelledCompounded or opened preparation
Principal limiting factorChemical and physical degradationMicrobiological risk, then chemical stability
Regulatory statusSubmitted and approvedAssigned under a compendial standard
Typical magnitude12–60 monthsHours to 180 days

Two consequences of the table are worth drawing out. Because the two dates are limited by different things, they respond differently to storage: refrigeration extends a microbiologically limited beyond-use date substantially and generally extends an expiration date not at all, since the expiration date already assumes the labelled condition. And because a beyond-use date is assigned rather than measured, it can be assigned correctly to a preparation that has in fact already degraded, if the degradation route was one the default table does not contemplate.[1][2]

References

  1. ^ a b c d United States Pharmacopeia, General Chapter <797>, "Pharmaceutical Compounding — Sterile Preparations", 2023 revision, including the beyond-use date tables for Category 1, 2 and 3 preparations.
  2. ^ a b United States Pharmacopeia, General Chapter <1191>, "Stability Considerations in Dispensing Practice" (informational). USP–NF, current revision.
  3. ^ a b International Council for Harmonisation, Q1A(R2): Stability Testing of New Drug Substances and Products (2003), read with Q1E: Evaluation for Stability Data (2003).